That is very important, due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (tech predictions). And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a development almost nobody saw. But it's going to have extensive ramifications for curing illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of financial investment chances in this space, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown latest prediction). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back possibly substantially prior to going greater - genetic sequencer stock jeff brown. I have actually been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. However that's not the big concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. biotech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many great private companies on the brink of striking the general public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This opportunity has been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the details. Go right here to schedule your spot totally free.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our normal beat (jeff brown biotech pick). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (jeff brown biotech genome sequencing). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and predict what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid growth and creating extraordinary chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown genome sequencing. However in spite of what many readers may believe, this is a trend that's just getting started. Even though the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (future report review). Losing two months of manufacturing and sales actually affects the number of 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million systems is exceptional. More significantly, the hold-ups caused by the pandemic created a lot of suppressed demand. And that need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G gadgets will be shipped in 2021 - second wave. And that's not my only 5G forecast When I've talked about 5G in the past, I've described its 3 various phases.
In Stage Two, 5G devices go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services start to be provided (jeff brown latest prediction). That's when we begin to see applications running on 5G networks. Consider things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage 3 by this summer season. This starts something of a virtuous cycle: The majority of people do not truly care about the technology. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of incredible applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment chances moving forward will be huge. Stepping away from 5G, the next important technology I foresee in 2021 is CRISPR hereditary editing. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And throughout that time, there were really just three companies running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating illness and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This entire market is effectively a greenfield opportunity.
There's space for lots of companies to exist in this area. jeff brown tech stock 2021. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug treatments produced utilizing this technology. This was among those developments that practically no one discovered. However it's going to have extensive ramifications for curing illness. And, of course, there will be lots of financial investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe substantially before going higher. I've been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin - jeff brown stock picks 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. But at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown stock predictions 2021. Mass, Mutual is a 150-year-old institution. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date since February 2021, however we could not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like capability to pick winning innovation stocks. He spent more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional viewpoint on the market. He's always on the hunt for brand-new chances, and he shares a number of his finest picks in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted a few of the greatest financial events of the past 20 years. Although he does not appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right every time, but Jeff Brown's precise predictions have made him legions of devoted followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study provides several research study services with a wide variety of specializations - jeff brown genetic sequencing stock.
The business is likewise associated with Bonner & Partners, another well-respected research study publisher - social media. On its website, Brownstone states its mission is to offer retail financiers with professional-grade research study: "For too long, the best financial investment research study has not been available to specific investors. It has actually been usually scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. united arab emirates. The mission of Brownstone Research study is to make that sort of proprietary research readily available to any financiers wanting to acquire an edge in the marketplaces. The objective is simple to provide unique and lucrative investment research study discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of stable success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you understand even a bit about the marketplace, you understand that he has a track record as a King Midas of sorts. exponential growth. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown thinks S.A.V. future report review. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying 2 cutting-edge technologies: artificial intelligence and electric automobiles. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving vehicles ever. It's nothing except the automotive industry's Holy Grail. As you know, electrical lorries and self-driving automobile stocks have actually been substantial this year, however the Wall Street device has been huge on hype without much tangible outcome. In spite of a drastic boost in competitors over the previous few years, Brown still thinks Musk has the very best opportunity of putting everything together.
tech might be the magic string that ties everything together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Generally, this innovation would enable you to lease out your automobile as a self-governing, self-driving taxi when you're not using it. You simply leave the vehicle and press a button on an app that tells the automobile to "join the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a substantial chunk of the revenues. It sounds insane, but it could be closed than you think.